CECOG has created a platform with the aim to reduce health inequalities and to improve patient access to cancer care. The subject of discussion is the value of new treatments to create willingness to invest in improving cancer outcomes while managing the budget. The platform includes various stakeholders as scientific leaders, policy makers, payers, patients and industry.

The origins of the GOIA initiative. Why was it created!

Cancer mortality varies widely across Europe, and survival depends on where you live. In particular, the inequality between countries in Central and South-Eastern Europe (CEE) and Western Europe (WE) is striking. The COVID-19 pandemic has brought existing inequalities into sharp focus, and the economic disruption it has caused threatens to deepen them.

How can we prevent this, and what is more, how can we drive lasting change towards equitable cancer care? Working within the frame of Europe’s “Beating Cancer” plan, the Central European Cooperative Oncology Group (CECOG) is running the “CEE Access to Cancer Care Program”.

Here, multisectoral experts have developed a Comprehensive Dashboard for CEE, comprising the whole pathway from prevention to survival by focusing on improved patients’ outcomes.

First NameLast Name Country19.11.2018 Vienna 29.03.2019 Bucharest 22.09.2019 Zagreb27.10.2019 Warsaw31.01.2020 Vienna
ChristophZielinskiCECOGATxxxxx
Christiane Thallinger CECOGATxxxxx
PatriciuAchimas CadariuMedical Director, Oncologic Institute Ion Chiricuta, Cluj, RomaniaROxx
TitAlbreht Centre for Health Care National Institute of Public Health, EUPHASLOxx
Ivica Belina Kuz - Coalition Of Association In HealthcareHRx
FlorinBuicuVicepresident
Committee for Health and Family
ROx
Cristian Silviu BusoiMember European ParliamentROxx
KrunoslavCapakCroatian National Institute of Public HealthHRX
AntonellaCardoneECPCUKxx
LarisaCatriniciOncology Institute of Chisinau MDAx
TudorCiuleanuProfessor of Oncology, Cluj NapocaROxx
Alina ComanescuFounder, Asociația Sănătate pentru Comunitate ROxxxxx
AdrianaCotelHealthcare Provider Strategies & Solutions S.R.L.ROx
TanjaCuferProfessor of Oncology, University Clinic Golnik, Medical Faculty LjubljanaSLOxxxx
PiotrCzaudernaconsultant at Medical University of Gdansk, Tri-City Central Animal Laboratory – Research and Service CentrePLx
DanaDeacJournalist. ROxx
AnaDodeaDirector, Policy & Market Access MSDROx
GertraudEckartMSDATxxxxx
RoxanaEneASTRA ZENECA Market Access DirectorROx
Alexander EniuSenior Medical Oncologist
Hopital Riviera-Chablais, CHE
ROx
RieFujisawaOECDx
RaduGanescuCOPAC - Coalition of Patients' Organisations with Chronic DiseasesROx
MirceaGeoanaASPEN RomaniaRO xx
StefanGijsselsChair
Patient Expert Center
BExx
SuzanneHakanssonASTRA ZENECA Vice President Healthcare AffairsSExx
Vera KatalinićJankovićCroatian Ministry of Health, Deputy Minister, responsible for National Cancer PlanHRx
Jacek JassemProfessor of Clinical Oncology and Radiotherapy
Medical University of Gdansk
PLxxxx
ZsuzsanaKahanProf of Oncology - Univ SzegedHUxx
RabiaKhanOECD RepresentativeUKxxx
BarbaraKiesewetter Medical University of Vienna
University Hospital for Internal Medicine I
ATx
JasperKunowManaging Director Central Eastern Europe at MSDCHx
AttilaLaszloChairman of Health Committee Senat of Rep. RomaniaRO x
SatuLipponenDir. Strategy & foresight Cancer Society of Finland SFx
PaulNaishAstraZenecaUKxxx
VladNicolaeActing Executive Director at Aspen Institute RomaniaROx
MartaNiculaieROCHE Communications DirectorROx
AnjaNitzsche-BellIAEA (Wien)ATxxx
CarmenOrbanProf. Dr. Anesthesiology and Intensive care Fundeni Clin InstituteROxxx
RenéOttMedical Director Oncology Europe, Astra Zeneca ATx x
PiotrPerkowskiMarket Access Manager AZPLx
AlojzPeterleformer MEPSLOx
Ivana PlechataVoice of PatientsCZx
MichaelPohlMarket Access, Astra ZenecaATx
BartoszPolinskiPatient Advocacy Fundacja Onkologgiczna AliviaPLxxxx
AlexandruRafilaASPEN RomaniaROxxx
RaduRasinarASTRA ZENECA Area Vice President CEEROxxx
Alexander RödigerMSD/European Federation of Pharmaceutical Industries and AssociationsCHxxxx
PiotrRutkowskiMaria Sklodowska-Curie Institute - Oncology CenterPLx
RafalSwierzewskiPresident of Board
Fundation for Patients with Rare Diseases COCARDA
PLxxxx
TomislavSokolMember European ParliamentHRx
KristineSorensenDirector, Global Health Literacy Academy DNKx
SandraSteyskalIAEA Section Head, Technical Cooperation EuropeATx
DubravkaSuicaMember European ParliamentHRx
Gabriela TeodorescuMedical and Regulatory Director, AstraZeneca Romania and Central Eastern EuropeROxxx
DamirVrbanecProf of Oncology - Univ. PulaHRxx
RazvanVulcancescuPresident, National Insurance House, RomaniaROxx
NilsWilkingAssociate Professor, Karolinska Institutet, StockholmSExxxx
WendyYaredDirector, Association of European Cancer Leagues (ECL)UKxx